-
Diagnostics World News | XPRIZE has announced five winning teams in the $6M XPRIZE Rapid Covid Testing competition. Chosen by an independent panel of judges, the winning solutions are radically affordable compared to what is currently available on the market, and are comparable to commercial offerings at measuring sensitivity, specificity, and limit of detection—with a maximum turnaround time of 12 hours from sample to result.
Mar 17, 2021
-
Diagnostics World News | Experts in basic medical sciences, biomedical engineering, and physics at Purdue University have collaborated to develop Doppler spectroscopy—the technique used to reveal the existence of extrasolar planetary systems—to study bacterial invasions of healthy tissue.
Mar 16, 2021
-
Diagnostics World News | Top COVID-19 news and research stories of the week: are symptom checkers helping or hurting? Could we stop the virus if everyone started weekly testing? And Thermo digs into mutations.
Mar 12, 2021
-
Diagnostics World News | Nanoengineering experts at the University of California (UC), San Diego have succeeded in developing an all-in-one health monitoring device that can reliably measure glucose, lactate, and blood pressure using a soft, stretchy skin patch the size of a postage stamp.
Mar 10, 2021
-
Diagnostics World News | New acquisitions and partnerships for Charles River, Illumina gets Russian approval, Lumos Diagnostics signs Canadian partnership, digital twin consortium, and more.
Mar 8, 2021
-
Diagnostics World News I Axillary adenopathy observed in some women after vaccination, specialized DNA probes analyze RNA sequences with more precision, new approach to pooled testing, elevated neutrophil biomarkers could predict severe outcomes, and two new calculators assess risk of in-hospital mortality or need for mechanical ventilation Plus: Coronavirus-like nanoparticles could serve as new positive controls for COVID-19 testing and a wastewater surveillance system in San Diego proves to be efficient and cost-effective.
Mar 5, 2021
-
Diagnostics World News | Researchers at Houston Methodist and MD Anderson Cancer Center have come up with a mathematical model for estimating the response of cancer patients to immunotherapy and, unlike most existing predictive tools in the clinic, it factors time into the equation.
Mar 4, 2021
-
Diagnostics World News | For many kinds of cancer, lifestyle and environmental factors are thought to be important drivers of disease risk. With prostate cancer, it’s a different story. So an international effort is seeking to develop a polygenic risk score that can better predict who is at risk of developing prostate cancer.
Mar 2, 2021
-
Diagnostics World News | New diagnostics for both SARS-CoV-2 and antigens Plus: how protected are we by prior infections?
Feb 26, 2021
-
Diagnostics World News | Therapies targeting a specific antibody, molecule, or cell promise to revolutionize the treatment of severe asthma by replacing the need to take oral corticosteroids. And a new urine-based assay aims to stratify responders from non-responders to the new biologic treatment regimens.
Feb 23, 2021
-
Diagnostics World News | 3-D printed nasopharyngeal swabs could solve resource problems, a closer look at COVID-19 diagnosis in Africa, and new diagnostic from Columbia University. Plus: EUA for COVID-19/flu combo test from Thermo Fisher, at-home tests in validation stages, and new vaccination panel.
Feb 19, 2021
-
Diagnostics World News | An innovative interrogation technique developed at Virginia Commonwealth University (VCU) is targeting genetic mutations that are neither very short nor very long and therefore get missed by existing diagnostic approaches.
Feb 17, 2021
-
Diagnostics World News | The intellectual property landscape for diagnostics can seem fraught with confusion. Tom Cowan, a partner at Knobbe Martens tackled some of the most common questions about IP issues that diagnostics companies are likely to face in 2021.
Feb 16, 2021
-
Diagnostics World News | New tools for predicting COVID-19 severity and death, and screening results of more than 1,000 at-home COVID-19 tests. Plus: detecting COVID-19 in wastewater, saliva-based testing for SARS CoV-2, uncovering the immunologic pathways of MIS-C.
Feb 12, 2021
-
Diagnostics World News | The European Union’s In Vitro Diagnostic Regulation (IVDR), introduced a new risk-based classification system, significantly impacting complementary and companion diagnostics. The IVDR also defines a CDx, for the first time in Europe, creating new challenges for device manufacturers and pharmaceutical companies producing CDx.
Feb 11, 2021
-
Diagnostics World News | Because coronavirus can spread before people become aware of their symptoms—or when they experience no symptoms whatsoever—some are turning to wearables as an early detection tool. By picking up on changes in certain metrics, smartwatches may be able to help curb transmission by providing indications of infection and nudging individuals to self-isolate or get tested sooner.
Feb 9, 2021
-
Diagnostics World News | Biomarker for patients with an increased risk of bleeding, detecting antibodies in minutes, self-swabbing just as accurate as those taken by healthcare workers, routine screening of asymptomatic healthcare personnel not an effective strategy, and breath-sampling whistle captures aerosols for COVID-19 testing. Plus: Startup develops test using genetically modified brewer’s yeast and George Mason University expands saliva-based testing on campus after successful results in the Fall.
Feb 5, 2021
-
Diagnostics World News | With the increasing number of FDA-approved targeted therapies and immunotherapies, comprehensive genomic profiling is becoming a standard diagnostic tool for patients with cancer. CGP is a test methodology that uses next-generation sequencing to simultaneously assess the four main classes of genomic alterations that may be responsible for driving cancer growth.
Feb 3, 2021
-
Diagnostics World News | As more targeted therapies become available to cancer patients based on the phenotype of their tumor, so too will understanding of the tumor habitats to reduce—and perhaps eventually eliminate—the need for biopsies before, during, and after treatment. That is the promise of computational approach being developed by researchers at the University of Cambridge (U.K.) combining routine computerized tomography (CT) and ultrasound (US) images to create a visual guide for doctors as they obtain tissue samples.
Feb 2, 2021
-
Diagnostics World News I New diagnostic assay allows testing and genomic surveillance simultaneously, a portable and bifunctional electrical detector for SARS-CoV-2, 1 in 3 infected asymptomatic. Plus: Melatonin produced in lungs could be used as a prognostic biomarker and machine learning predicts COVID-19 patient outcomes.
Jan 29, 2021